Oxford-based iotaSciences, a leader in single-cell biology handling solutions, raised an undisclosed amount in an equity funding round. Founded in 2016 and led by Dr. Michael Lutz, iotaSciences’ solutions are crucial for R&D workflows in Cell and Gene Therapy (CGT) and other applications.